Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
342 Leser
Artikel bewerten:
(2)

UST Announces Strategic Transaction with Bain Capital to Propel Next Phase of Growth

UST HealthProof divestment positions UST to maintain growth in enterprise AI, transformation, engineering and other dynamic market segments

LONDON, Sept. 4, 2025 /PRNewswire/ -- UST, a leading AI and technology transformation solutions company, has successfully closed its transaction with Bain Capital involving UST HealthProof, a subsidiary of UST that provides solutions for core administration and clinical operations across all lines of business. As part of this transaction, UST HealthProof will combine with HealthEdge, creating one of the healthcare industry's leading next-generation platforms for payers.

UST_Logo

For UST, this move marks a deliberate and strategic step in its growth and transformation journey. By divesting UST HealthProof, UST has aligned its strategic focus around high-growth areas such as enterprise AI, cloud transformation, data modernization, and platform engineering. These capabilities are reshaping the digital future for clients across healthcare, BFSI, retail, and other industries, and UST is committed to further enhancing its leadership position in these key sectors to increase solutions and benefits to payers, providers, and clients.

UST remains one of the largest and fastest-growing healthcare technology solutioning enterprises, with a 5,000+ strong healthcare team, and more than 20 years of industry expertise. The company serves all the top five U.S. healthcare payers, more than 50 leading U.S. healthcare systems, as well as global pharmaceutical and life sciences leaders. With a customer retention rate of more than 98% over the last five years, UST remains a trusted partner for payers and providers in addition to pharma and healthtech companies.

At the same time, UST HealthProof begins its next chapter with Bain Capital and HealthEdge. With its dedicated investment and leadership structure, UST HealthProof will be positioned to scale more rapidly, explore new partnerships, and continue delivering innovation for its clients.

UST was instrumental in the growth and evolution of UST HealthProof, a testament to its longstanding expertise in fostering robust, innovative, and effective client-focused platforms. The two companies will continue to maintain a strong relationship, ensuring continuity for shared customers and ongoing collaborations.

"Today's announcement reflects both the strength of what we have built and the clarity of our vision for the future. This milestone allows UST to focus on the transformative technologies we lead in. It also ensures that UST HealthProof, with the backing of Bain Capital, can unlock new opportunities for growth and innovation. It is a win for our clients, our people, and the industry at large," said Krishna Sudheendra, Chief Executive Officer, UST.

This development aligns with UST's long-standing and successful growth strategy by helping the company to remain agile, accelerating innovation, and creating lasting value for clients and employees worldwide.

Goldman Sachs and J.P. Morgan Securities LLC acted as financial advisors and Davis Polk & Wardwell, LLP as legal counsel to UST.

About UST

Since 1999, UST has worked side by side with the world's best companies to make a powerful impact through transformation. Powered by technology, driven by AI, inspired by people, and led by our purpose, we partner with our clients from design to operation. Our AI-driven digital solutions, proprietary platforms, engineering, R&D, products, and innovation ecosystem turn core challenges into impactful, disruptive solutions. With deep industry knowledge and a future-ready mindset, we infuse expertise, innovation, and agility into our clients' organizations-delivering measurable value and positive lasting change for them, their customers, and communities around the world. Together, with 30,000+ employees in 30+ countries, we build for boundless impact-touching billions of lives in the process. Visit us at www.UST.com.

Media Contacts, UST:

Tinu Cherian Abraham
+1 (949) 415-9857

Merrick Laravea
+1 (949) 416-6212

Neha Misri
+44-7341787926

Roshni Das K
+91 7736795557
media.relations@ust.com

Media Contacts, U.S.:
S&C PR
+1-646.941.9139
media@scprgroup.com

Makovsky
ust@makovsky.com

Media Contacts, India:
ust@adfactorspr.com

Media Contacts, U.K.:
FTI Consulting
UST@fticonsulting.com

Logo: https://mma.prnewswire.com/media/1422658/5348838/UST_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/ust-announces-strategic-transaction-with-bain-capital-to-propel-next-phase-of-growth-302546549.html

© 2025 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.